ArticleInvestigational new drugs2006

A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies.

G Schwartsmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.